Edwards Lifesciences Corporation
Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS fell 26.3%, free cash flow grew 142.8% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow EW
Edwards Lifesciences Corporation (EW) EV/FCF
As of 16 October 2026, Edwards Lifesciences Corporation (EW) trades at a EV/FCF of 33.4×. Over the past ten years it has ranged from 13.4× (January 2015) to 224× (April 2024); the current reading is higher than 7% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 35.9× | (77.51%) |
| FY2024 | 160× | 121.18% |
| FY2023 | 72.1× | 48.99% |
| FY2022 | 48.4× | (15.65%) |
| FY2021 | 57.4× | (35.10%) |
| FY2020 | 88.5× | 65.77% |
| FY2019 | 53.4× | 13.22% |
| FY2018 | 47.1× | 66.12% |
| FY2017 | 28.4× | (31.10%) |
| FY2016 | 41.2× | 8.33% |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 35.0× | (15.61%) |
| Mar 2026 | 41.4× | 15.50% |
| Dec 2025 | 35.9× | (35.14%) |
| Sep 2025 | 55.3× | (28.30%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| PHG Koninklijke Philips N.V. compare | 16.1× |
| BSX Boston Scientific Corporation compare | 21.3× |
| MDT Medtronic PLC compare | 22.9× |
| DXCM DexCom, Inc. compare | 23.5× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 24.4× |
| STE STERIS plc compare | 24.7× |
| GEHC GE HealthCare Technologies Inc. compare | 25.9× |
| SYK Stryker Corporation compare | 26.5× |
| EW Edwards Lifesciences Corporation | 33.4× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on EW
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement